Compare McKesson Corporation (MCK) vs Norfolk Southern Corporation (NSC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Norfolk Southern Corporation — how do they compare? McKesson Corporation trades at $824.07 (market cap $97.35B), while Norfolk Southern Corporation trades at $334.95 (market cap $75.23B). The key difference: McKesson Corporation is the larger of the two by market cap, and Norfolk Southern Corporation pays the higher dividend (1.61%). Which is the better fit depends on your goals.
| MCK | NSC | |
|---|---|---|
Market Cap | $97.35B | $75.23B |
Sector | Health | Technology |
52-Week High | $995.69 | $340.16 |
52-Week Low | $659.01 | $272.35 |
Enterprise Value | $101.98B | $90.99B |
Dividend Yield | 0.39% | 1.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Norfolk Southern (NSC) trades at $334.97, down 1.53% today, with a bullish technical outlook from moving averages but overbought RSI signals. The company shows strong profitability with a 21.91% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights the pending merger with Union Pacific and upcoming Q2 2026 earnings on July 23, 2026.
The stock offers a moderate upside to the $344.40 consensus price target, supported by earnings momentum and cost controls, but faces risks from regulatory scrutiny of the merger and rich valuations. Investor sentiment is mixed amid merger uncertainties and high expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →
